Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
Butterfly Network Inc (BFLY)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/11/2025: BFLY (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
4 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $4.17
1 Year Target Price $4.17
| 4 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -54.77% | Avg. Invested days 24 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 07/11/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 447.59M USD | Price to earnings Ratio - | 1Y Target Price 4.17 |
Price to earnings Ratio - | 1Y Target Price 4.17 | ||
Volume (30-day avg) 4 | Beta 2.55 | 52 Weeks Range 0.90 - 4.98 | Updated Date 07/12/2025 |
52 Weeks Range 0.90 - 4.98 | Updated Date 07/12/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.3 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -75.56% | Operating Margin (TTM) -83.69% |
Management Effectiveness
Return on Assets (TTM) -13.86% | Return on Equity (TTM) -29.16% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 314633962 | Price to Sales(TTM) 5.23 |
Enterprise Value 314633962 | Price to Sales(TTM) 5.23 | ||
Enterprise Value to Revenue 3.67 | Enterprise Value to EBITDA -9.57 | Shares Outstanding 220862000 | Shares Floating 190061326 |
Shares Outstanding 220862000 | Shares Floating 190061326 | ||
Percent Insiders 14.45 | Percent Institutions 45.98 |
Upturn AI SWOT
Butterfly Network Inc
Company Overview
History and Background
Butterfly Network, Inc. was founded in 2011 by Jonathan Rothberg. It went public in February 2021 via a SPAC merger with Longview Acquisition Corp. Butterfly focuses on democratizing healthcare through its handheld, whole-body ultrasound technology.
Core Business Areas
- Butterfly iQ+: Develops, manufactures, and commercializes the Butterfly iQ+, a single-probe, whole-body ultrasound device. It's used in various medical settings for imaging and diagnostics.
- Butterfly Cloud: Offers a cloud-based software platform for image storage, collaboration, and analysis. It integrates with the Butterfly iQ+ to provide a comprehensive imaging solution.
- Subscription Services: Provides ongoing services, including education, support, and software updates, to users of the Butterfly iQ+ and Butterfly Cloud.
Leadership and Structure
Dr. Joseph DeVivo is the CEO. The organizational structure includes departments for research and development, sales and marketing, operations, and finance.
Top Products and Market Share
Key Offerings
- Butterfly iQ+: A handheld, single-probe, whole-body ultrasound device. Competitors include GE Healthcare, Philips, and Siemens Healthineers. Market share data is variable, but Butterfly aims to disrupt traditional ultrasound markets by offering a more affordable and accessible solution.
- Butterfly Cloud: A cloud-based software platform for managing ultrasound images and facilitating collaboration. Competitors include other medical imaging software providers like Sectra and Change Healthcare. Revenue from this segment is integrated within overall Butterfly Network revenues.
Market Dynamics
Industry Overview
The ultrasound market is growing, driven by increasing demand for point-of-care diagnostics and minimally invasive procedures. Technological advancements, such as miniaturization and AI-powered analysis, are further fueling growth.
Positioning
Butterfly Network is positioned as a disruptor in the ultrasound market. Its competitive advantages include the compact size, affordability, and ease of use of its Butterfly iQ+ device.
Total Addressable Market (TAM)
The global ultrasound market is estimated to be around $8 billion. Butterfly Network is positioned to capture a significant portion of this by offering a low-cost and accessible device.
Upturn SWOT Analysis
Strengths
- Affordable, portable ultrasound technology
- Cloud-based platform for image management
- Strong brand recognition among early adopters
- FDA cleared for multiple applications
Weaknesses
- Limited market share compared to established players
- Relatively short operational history as a public company
- High marketing and sales expenses
- Reliance on subscription revenue
Opportunities
- Expanding into emerging markets
- Developing new AI-powered diagnostic tools
- Partnering with telehealth providers
- Growing adoption of point-of-care ultrasound
Threats
- Competition from established medical imaging companies
- Regulatory changes affecting medical devices
- Economic downturn impacting healthcare spending
- Technological obsolescence
Competitors and Market Share
Key Competitors
- GE (GE)
- PHG (PHG)
- SI (Siemens Healthineers. Stock Symbol: SHI)
Competitive Landscape
Butterfly Network's competitive advantage lies in its low-cost, portable ultrasound technology. However, it faces intense competition from established players with broader product portfolios and stronger distribution networks.
Growth Trajectory and Initiatives
Historical Growth: Butterfly Network has demonstrated revenue growth since its launch, driven by increasing adoption of its Butterfly iQ+ device. However, profitability remains a challenge.
Future Projections: Analysts predict continued revenue growth for Butterfly Network, driven by expansion into new markets and the development of new applications for its technology. Profitability is expected to improve over time.
Recent Initiatives: Recent initiatives include partnerships with healthcare providers, expansion of the Butterfly Cloud platform, and development of AI-powered diagnostic tools.
Summary
Butterfly Network offers a disruptive and affordable ultrasound solution, yet remains unprofitable. Revenue growth is promising but faces intense competition. The company needs to focus on profitability and expanding its market share and it is vital that the company reduces burn. Overall, the company is considered moderately weak.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings (SEC)
- Analyst reports
- Market research reports
Disclaimers:
This analysis is based on publicly available information and should not be considered investment advice. Market share data is approximate and may vary.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Butterfly Network Inc
Exchange NYSE | Headquaters Burlington, MA, United States | ||
IPO Launch date 2020-07-13 | CEO, President & Chairman of the Board Mr. Joseph M. DeVivo | ||
Sector Healthcare | Industry Medical Devices | Full time employees 190 | Website https://www.butterflynetwork.com |
Full time employees 190 | Website https://www.butterflynetwork.com | ||
Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. The company offers Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging on a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; Butterfly iQ+ Bladder, a specialty product for the bladder scanning market; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. It also provides Butterfly system, which includes probes, related accessories, and software subscriptions to healthcare systems, physicians, and healthcare providers. In addition, the company offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software and Butterfly Certified courses, as well as professional services for large scale deployments; and ScanLab, an education-only app that provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. It sells its products through a direct sales force, distributors, and e-commerce channels. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.